Investor Daily: Why Novo Nordisk Can’t Beat Eli Lilly – The Pharma Drug War
In this Market Mondays clip, Rashad Bilal and Ian Dunlap dive deep into the recent struggles of Novo Nordisk and explain why the stock’s steep drop isn’t an opportunity to […]